Ceftazidime: all 25 studies that test it
Page 1 of 1. Open to participants first (3), then studies with results posted, then the rest; newest registration first within each.
- Restrictive Versus Standard Antibiotic Treatment During CAR-T TherapyNot yet recruitingNCT07842198Phase 2
- Early Optimization of Ceftazidime Regimen in Critical CareNot yet recruitingNCT07085624Not applicable
- Ciprofloxacin vs Ceftazidime for Empirical Treatment of High-Risk Neutropenic Fever in Children With Hematologic MalignanciesRecruitingNCT07016165Phase 4
- A Study of Avycaz (Ceftazidime/Avibactam) Pharmacokinetics/Pharmacodynamics (PK/PD) in Critically Ill PatientsCompletedNCT02822950Phase 1Results posted
- Vancomycin Plus Moxifloxacin Versus Vancomycin Plus Ceftazidime for the Treatment of Peritoneal Dialysis (PD)-Related PeritonitisCompletedNCT02787057Not applicableResults posted
- Steady-state Pharmacokinetics of Ceftazidime/Avibactam in Cystic FibrosisCompletedNCT02504827Phase 4Results posted
- Prospective Multicenter Doubleblind Randomized Study of NXL104/Ceftazidime + Metronidazole vs. Meropenem in Treatment of Complicated Intra-abdominal InfectionsCompletedNCT00752219Phase 2Results posted
- Comparative Study of NXL104/Ceftazidime Versus Comparator in Adults With Complicated Urinary Tract InfectionsCompletedNCT00690378Phase 2Results posted
- Early Versus Late Stopping of Antibiotics in Children With Cancer and High-risk Febrile NeutropeniaCompletedNCT04948463Phase 4
- LC-MS/MS Based Method Development for the Monitoring of Antibiotic Concentrations in Sputum of Cystic Fibrosis PatientsTerminatedNCT02840136Not applicable
- Lung Concentrations of Ceftazidime in Patients With Ventilator-associated PneumoniaCompletedNCT02837835Phase 3
- Cystic Fibrosis Microbiome-determined Antibiotic Therapy Trial in Exacerbations: Results StratifiedCompletedNCT02526004Not applicable
- Short vs Prolonged Antibiotic Treatment for Hospitalized Hemato-oncology Patients With Febrile NeutropeniaStatus unknownNCT02463747Phase 4
- Single Versus Combined Antibiotic Therapy for Bacterial Peritonitis in CAPD PatientsCompletedNCT01785641Not applicable
- Post ERCP Pancreatitis Prevention in Average Risk PatientsCompletedNCT01784445Phase 4
- A Study to Assess the Levels of Two Antibiotics in the Blood When Given Together and SeparatelyCompletedNCT01430910Phase 1
- Population Pharmacokinetics of Anti-infectious Drugs in ChildrenCompletedNCT01344512Not applicable
- A Single-centre, Randomised, Double-blind, Placebo-controlled, Four Way Crossover Phase I Study to Investigate the Effect on QT/QTc Interval of Ceftazidime NXL104 or Ceftaroline Fosamil NXL104, Compared With Placebo, Using Moxifloxacin (Avelox®) as a Positive Control, in Healthy Male VolunteersCompletedNCT01290900Phase 1
- Duration of Antibiotics in Infective Exacerbations of Cystic FibrosisStatus unknownNCT01044719Phase 4
- Comparison of Antibiotics for Pseudomonas in Early CFCompletedNCT00823238Phase 1
- Nebulized Ceftazidime and Amikacin in Ventilator Associated PneumoniaCompletedNCT00786305Phase 2
- Ceftazidime Pharmacokinetic in Cerebrospinal Fluid Between Continuous and Intermittent AdministrationStatus unknownNCT00752882Phase 2
- Continuous Versus Short Infusions of Ceftazidime in Cystic FibrosisTerminatedNCT00333385Phase 4
- Adverse Drug Reactions of Different Brands of Ceftazidime InjectionStatus unknownNCT00173901Phase 4
- Standard vs. Biofilm Susceptibility Testing in Cystic Fibrosis (CF)CompletedNCT00153634Not applicable